Comera Life Financials
This page shows Comera Life (CMRA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2022 annual data. Scores normalized against common benchmarks. How we calculate these scores
Comera Life has an operating margin of -1890.7%, meaning the company retains $-1891 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from -1730.8% the prior year.
Comera Life's revenue surged 97.9% year-over-year to $633K, reflecting rapid business expansion. This strong growth earns a score of 100/100.
Comera Life's current ratio of 0.61 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 4/100, which could limit financial flexibility.
While Comera Life generated -$9.8M in operating cash flow, capex of $29K consumed most of it, leaving -$9.8M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Comera Life passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, Comera Life generates $0.54 in operating cash flow (-$9.8M OCF vs -$18.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Comera Life earns $-587.0 in operating income for every $1 of interest expense (-$12.0M vs $20K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Comera Life generated $633K in revenue in fiscal year 2022. This represents an increase of 97.9% from the prior year.
Comera Life's EBITDA was -$11.9M in fiscal year 2022, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 117.9% from the prior year.
Comera Life generated -$9.8M in free cash flow in fiscal year 2022, representing cash available after capex. This represents a decrease of 151.3% from the prior year.
Comera Life reported -$18.0M in net income in fiscal year 2022. This represents a decrease of 230.2% from the prior year.
Comera Life earned $-1.76 per diluted share (EPS) in fiscal year 2022. This represents an increase of 2.8% from the prior year.
Comera Life held $447K in cash against $0 in long-term debt as of fiscal year 2022.
Comera Life had 17M shares outstanding in fiscal year 2022. This represents an increase of 5317.3% from the prior year.
Comera Life's gross margin was 66.8% in fiscal year 2022, indicating the percentage of revenue retained after direct costs. This is up 17.1 percentage points from the prior year.
Comera Life's operating margin was -1890.7% in fiscal year 2022, reflecting core business profitability. This is down 159.9 percentage points from the prior year.
Comera Life's net profit margin was -2843.8% in fiscal year 2022, showing the share of revenue converted to profit. This is down 1139.2 percentage points from the prior year.
Comera Life invested $1.7M in research and development in fiscal year 2022. This represents a decrease of 0.7% from the prior year.
Comera Life invested $29K in capex in fiscal year 2022, funding long-term assets and infrastructure. This represents a decrease of 79.9% from the prior year.
CMRA Income Statement
| Metric | Q3'23 | Q2'23 | Q1'23 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $136K-56.7% | $315K-19.8% | $393K+151.7% | $156K+6.4% | $147K+53.9% | $95K | N/A | $88K |
| Cost of Revenue | $42K-25.1% | $56K-51.9% | $117K+131.4% | $50K-7.7% | $55K+22.5% | $45K | N/A | $48K |
| Gross Profit | $94K-63.6% | $259K-6.3% | $276K+161.3% | $106K+14.7% | $92K+81.4% | $51K | N/A | $39K |
| R&D Expenses | $366K+55.3% | $236K-31.4% | $344K-29.8% | $489K+32.8% | $369K-24.4% | $487K | N/A | $264K |
| SG&A Expenses | $1.9M+25.4% | $1.5M-38.2% | $2.4M-7.3% | $2.6M-29.0% | $3.7M+83.3% | $2.0M | N/A | $689K |
| Operating Income | -$2.2M-45.7% | -$1.5M+40.8% | -$2.5M+16.9% | -$3.0M+24.3% | -$4.0M-62.0% | -$2.5M | N/A | -$914K |
| Interest Expense | $6K+50.0% | $4K-47.8% | $8K-40.0% | $13K | N/A | $77 | N/A | N/A |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | N/A | $0 |
| Net Income | -$2.2M-52.6% | -$1.4M+43.1% | -$2.5M+16.2% | -$3.0M+67.4% | -$9.1M-215.5% | -$2.9M | N/A | -$914K |
| EPS (Diluted) | $-0.10-25.0% | $-0.08+38.5% | $-0.13-103.6% | $3.59+414.9% | $-1.14+71.6% | $-4.01 | N/A | $-6.34 |
CMRA Balance Sheet
| Metric | Q3'23 | Q2'23 | Q1'23 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.1M+31.3% | $2.3M-22.0% | $3.0M-19.5% | $3.7M-39.2% | $6.1M | N/A | $7.4M | N/A |
| Current Assets | $2.6M+44.2% | $1.8M-24.2% | $2.4M-21.4% | $3.1M-43.4% | $5.4M | N/A | $6.8M | N/A |
| Cash & Equivalents | $1.8M+271.2% | $476K-69.0% | $1.5M+244.5% | $447K-91.0% | $4.9M+27.8% | $3.9M-40.7% | $6.5M-21.3% | $8.3M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | $250K | N/A | $34K-65.7% | $100K | N/A | $0 | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $7.3M-16.1% | $8.7M+5.2% | $8.3M-17.1% | $10.0M+25.9% | $7.9M | N/A | $22.1M | N/A |
| Current Liabilities | $2.9M-25.8% | $4.0M+17.8% | $3.4M-33.7% | $5.1M+100.4% | $2.5M | N/A | $1.0M | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$4.2M+33.5% | -$6.4M-20.6% | -$5.3M+15.7% | -$6.2M-248.6% | -$1.8M+89.5% | -$17.1M-16.4% | -$14.7M-7.5% | -$13.7M |
| Retained Earnings | -$41.0M-5.6% | -$38.8M-3.8% | -$37.4M-7.1% | -$34.9M-20.9% | -$28.9M | N/A | -$16.9M | N/A |
CMRA Cash Flow Statement
| Metric | Q3'23 | Q2'23 | Q1'23 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.9M-92.7% | -$994K+47.9% | -$1.9M-3.1% | -$1.8M+30.7% | -$2.7M+7.1% | -$2.9M-79.0% | -$1.6M-71.7% | -$934K |
| Capital Expenditures | $0-100.0% | $6K-93.6% | $88K | $0 | N/A | N/A | $131K | N/A |
| Free Cash Flow | -$1.9M-91.6% | -$999K+49.9% | -$2.0M-7.9% | -$1.8M | N/A | N/A | -$1.7M | N/A |
| Investing Cash Flow | $0+100.0% | -$6K+93.6% | -$88K | $0 | N/A | N/A | -$131K | N/A |
| Financing Cash Flow | $3.2M+5172.3% | -$63K-104.0% | $1.6M+39.8% | $1.1M-69.8% | $3.7M+1582.7% | $223K | $0-100.0% | $2.3M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
CMRA Financial Ratios
| Metric | Q3'23 | Q2'23 | Q1'23 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.2%-13.0pp | 82.2%+11.9pp | 70.3%+2.6pp | 67.7%+4.9pp | 62.8%+9.5pp | 53.3% | N/A | 44.9% |
| Operating Margin | -1582.5%-1112.6pp | -469.8%+166.6pp | -636.4%+1291.0pp | -1927.4%+780.3pp | -2707.7%-135.0pp | -2572.7% | N/A | -1041.1% |
| Net Margin | -1580.0%-1132.0pp | -448.1%+183.5pp | -631.5%+1266.1pp | -1897.6%+4294.4pp | -6192.0%-3171.7pp | -3020.3% | N/A | -1041.1% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -70.1%-9.8pp | -60.3%+22.4pp | -82.7%-3.2pp | -79.5%+68.7pp | -148.2% | N/A | N/A | N/A |
| Current Ratio | 0.90+0.4 | 0.46-0.3 | 0.72+0.1 | 0.61-1.5 | 2.14 | N/A | 6.49 | N/A |
| Debt-to-Equity | -1.73-0.4 | -1.37+0.2 | -1.57+0.0 | -1.60+2.8 | -4.42 | N/A | -1.51 | N/A |
| FCF Margin | -1404.2%-1087.0pp | -317.1%+190.4pp | -507.5%+676.0pp | -1183.5% | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$6.2M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.61), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Comera Life's annual revenue?
Comera Life (CMRA) reported $633K in total revenue for fiscal year 2022. This represents a 97.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Comera Life's revenue growing?
Comera Life (CMRA) revenue grew by 97.9% year-over-year, from $320K to $633K in fiscal year 2022.
Is Comera Life profitable?
No, Comera Life (CMRA) reported a net income of -$18.0M in fiscal year 2022, with a net profit margin of -2843.8%.
What is Comera Life's earnings per share (EPS)?
Comera Life (CMRA) reported diluted earnings per share of $-1.76 for fiscal year 2022. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Comera Life's EBITDA?
Comera Life (CMRA) had EBITDA of -$11.9M in fiscal year 2022, measuring earnings before interest, taxes, depreciation, and amortization.
What is Comera Life's gross margin?
Comera Life (CMRA) had a gross margin of 66.8% in fiscal year 2022, indicating the percentage of revenue retained after direct costs of goods sold.
What is Comera Life's operating margin?
Comera Life (CMRA) had an operating margin of -1890.7% in fiscal year 2022, reflecting the profitability of core business operations before interest and taxes.
What is Comera Life's net profit margin?
Comera Life (CMRA) had a net profit margin of -2843.8% in fiscal year 2022, representing the share of revenue converted into profit after all expenses.
What is Comera Life's free cash flow?
Comera Life (CMRA) generated -$9.8M in free cash flow during fiscal year 2022. This represents a -151.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Comera Life's operating cash flow?
Comera Life (CMRA) generated -$9.8M in operating cash flow during fiscal year 2022, representing cash generated from core business activities.
What are Comera Life's total assets?
Comera Life (CMRA) had $3.7M in total assets as of fiscal year 2022, including both current and long-term assets.
What are Comera Life's capital expenditures?
Comera Life (CMRA) invested $29K in capital expenditures during fiscal year 2022, funding long-term assets and infrastructure.
How much does Comera Life spend on research and development?
Comera Life (CMRA) invested $1.7M in research and development during fiscal year 2022.
How many shares does Comera Life have outstanding?
Comera Life (CMRA) had 17M shares outstanding as of fiscal year 2022.
What is Comera Life's current ratio?
Comera Life (CMRA) had a current ratio of 0.61 as of fiscal year 2022, which is below 1.0, which may suggest potential liquidity concerns.
What is Comera Life's debt-to-equity ratio?
Comera Life (CMRA) had a debt-to-equity ratio of -1.60 as of fiscal year 2022, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Comera Life's return on assets (ROA)?
Comera Life (CMRA) had a return on assets of -483.1% for fiscal year 2022, measuring how efficiently the company uses its assets to generate profit.
What is Comera Life's cash runway?
Based on fiscal year 2022 data, Comera Life (CMRA) had $447K in cash against an annual operating cash burn of $9.8M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Comera Life's debt-to-equity ratio negative or unusual?
Comera Life (CMRA) has negative shareholder equity of -$6.2M as of fiscal year 2022, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Comera Life's Piotroski F-Score?
Comera Life (CMRA) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Comera Life's earnings high quality?
Comera Life (CMRA) has an earnings quality ratio of 0.54x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Comera Life cover its interest payments?
Comera Life (CMRA) has an interest coverage ratio of -587.0x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Comera Life?
Comera Life (CMRA) scores 26 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.